{"name":"Vifor (International) Inc.","slug":"vifor-international-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQN2hoZXpWUUNHS0JURlA0TDRlLVlPVTlZbGotZVREeUtKUFI3bHA2UmRxaTRHNlRWLWw3RXhhVzJ1aElvV0NLOGI0UlRmWnE1am1UMEpqZVdlWTUyM1Y4LTdXV3R4Ti1fV3BoV3hBZVYybmhSV2ZMTl9qalNxWlBzbDJRVDR5RDZwUW12ZDRsWVN2Y1EzcWVpUW9mTWtfejVUbFVfemxQbVlXdUQtY1FLM3dXeURFbHp1cV9yb083N0txLXd2ZWJWeENOc0dqWGg4RjNHOWR5YTdfM25OdGY1Wnd4ODJudlRHZFpxZ2daUm1STThGSXc?oc=5","date":"2025-09-26","type":"pipeline","source":"PR Newswire","summary":"CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy - PR Newswire","headline":"CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxONndadnpLc3JuclR2czF4aUVSQTFPNjZxOFd4cVR1NFVVb2I2OGZJS09Odl9lNXllemNTU3Q2TW5Mck5iSzh2ZHYzcEhpNk0tLVViRUFja0pROWo1cEs0QXo0MlJNbnBXY0F3Z216cFl0WURLaWZhYVlycmFkRnl5cmZxWUFZSEk3Rk9DYV9IUDZGODNMTHYtc2dKVlJOT3oyanFUQ2g4VS1XOXdZN2U0cTVMZGo3TE85UGVNZVVBZ2YwT0N2UGZncGJRU19yUm9pY1BiSURFUmY2bVpMVHRJZnM1LWhwYjA?oc=5","date":"2025-04-29","type":"regulatory","source":"PR Newswire","summary":"CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy - PR Newswire","headline":"CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZ1lyM3UyZFhDYTNkeE1CNHhtU1JDZlFubnRFUkU2Tm9DVVlyN2E1ZzR2c2hVQlpJMm9xTTNtS3N0VzRIM0JVNTNOZ2FOcnBUUEotNXZNRW9JcjdnWFBVeENveDQ2SzAwN0NKOVJHeGVyRUdMQVg3ckg4RFE0d1JhYzZNMUpYRmNJeVA5WmJHeHRVTFVpcUl0ajZBU2RQX2NEcmtsbjg5OWFZZnhsaUpXcEV0NUVScHBRbDloS1RHMDRldw?oc=5","date":"2024-04-19","type":"pipeline","source":"Reuters","summary":"Vifor Pharma offers to fix alleged anti-competitive behaviour - Reuters","headline":"Vifor Pharma offers to fix alleged anti-competitive behaviour","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNWTRpeXN0NzFySE0tcXphZUFfczNzQnJ5VzIyRGpCRUpsNFZjY0FKNzdFNGh1TDFFX2luTzdwMTBsMUQzcDhHcExOTnhsWkNpZGlJWWNraE84Vk5EY2JsVTRGRC1DX25oUzRNemdDY3BJSXVYSnRiS0ExR2RreF94T1Y1bjlfaVc4Rnd5cTFMdXJpMldJQ29rV0YycGR0a3pNWXVLWWFZN1h5UQ?oc=5","date":"2024-03-06","type":"patent","source":"IAM Patent","summary":"Landmark ruling in pharma appeal cements scope of product-by-process claims - IAM Patent","headline":"Landmark ruling in pharma appeal cements scope of product-by-process claims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPeUF3QlBHWENkMHJtTGhIM1d5LURzanlONXBaUEkwaFB4SFJfUnd5d0hqRVd2bjVYcWZPT0RTQTFnc3ozRmF1LXFTaWFXOHB3YUVaNDU5Qnppa2hmcE5QYkI2RkJ6Wk1LdUZSNG1SdkZPRDBXbDZ5VEk5Nkp1RHZ5d0tRc2lCY3MtUlFpOHBPOGZEYU5DaFdvbVg2M3kzS3JjYlU5dEEzd05fdXZaYTJzNnZfRWJFVWtrbEhTOWtuRk5LcG9Dem9DMU83NzZ5WEpkZHRkUFVUQV9lcVQ3TElOQ1FQWFY?oc=5","date":"2023-11-24","type":"pipeline","source":"PR Newswire","summary":"Iron Deficiency Day 2023: CSL Vifor calls for access to iron deficiency diagnosis and treatment - PR Newswire","headline":"Iron Deficiency Day 2023: CSL Vifor calls for access to iron deficiency diagnosis and treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1wYWlyaTJNNjB3UGxyRkxkMmtNUjAwS2NFMFR0UU5RejFxS0ViSzROQS1RWVV1d01aRDk2NFkydUNpZFhHQTJWaDJwVjNjUnFmdmc4aFd3aXBicFRvWjFaV2d3RjJmTHNVM3VaanZLNF9CZ0ZWSnA4?oc=5","date":"2023-06-01","type":"pipeline","source":"Global Biotechnology Company","summary":"Global Biotechnology Company - Global Biotechnology Company","headline":"Global Biotechnology Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQRTJyZ2dibWp1SEJaMW80TzZVdlhtckYyY1RrbEhLSTVHX1NCa01TSlpBbXh3eXFvS1hSSXduVkI4aF9nWGJpbHFsdkdVV05QUFlkYjItOTEtTHE2UEJCR2x1Q1ptUXVmSkNTZnBZSjNTOFlzdTdGLVZmVVE1MUdjd0RhUWpuQ2VHYmJyNjZZOHV6SXdYNmNubVQ5M2tTdmhxV3lNY0pUVTdvUEN5Rm5fN0tRXy01MzdLeEZick5DdnRUMXNhczM4dzFVa0ZyeVBsSFRub2pzNElLSl9lV0hyeFpvWWhBSktLS2J2bktFd1otZTRMRjdKVU9HX0I?oc=5","date":"2022-03-08","type":"pipeline","source":"businesswire.com","summary":"Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful - businesswire.com","headline":"Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNWjJTMmNWZVQwVDhmT0hta1hiX3FKUGMwLVBQZ3B1UlRObGwycVpqS0hHeDhoLUpmRTJwSUItSENoRVF2RDZOUE1aQmVLZ1ZPNXFXamlmZ3FCMmVHMU9xMGNJQXlfd2hwaTVRM2ZjRTRIVy1IWkN5YzFrX2hralk4RXphaHYtcGRTRXc?oc=5","date":"2022-02-23","type":"pipeline","source":"Pharmacy Times","summary":"Korsuva From Cara Therapeutics and Vifor Pharma - Pharmacy Times","headline":"Korsuva From Cara Therapeutics and Vifor Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPZTVPN3VRLTlSaFBaYjVkTVI5T1JJaWFuM0tFbFpKUkNqelhLbHZDUG82UGlTVS1VMUtjWlRRSXNSZVFCam8ycXlkODNGR1o4bXRRT01aMVBQMGRlajg4LVlfXzN6dHlEVzRLUTRDZVpQY2lYRWlac2hXTnZnUUdnTWwwMHZVaG5iODlYWVVCY0JnSjduTGJyOFlmYUNpSHlCOEZULVFOQ2VRNVpzN1E?oc=5","date":"2021-12-23","type":"deal","source":"Global Biotechnology Company","summary":"CSL to Acquire Vifor Pharma, a Leader in Kidney Care - Global Biotechnology Company","headline":"CSL to Acquire Vifor Pharma, a Leader in Kidney Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPdTJUcTg1a3RlVFZXVUFQVERlQ3J2eldySFlFSi15ay1xcnRaWHZDRC1pbm5XTVRhN3ZRbEhwd2ZmZ3RZOWs4MDNKeExiU0JlRElRWlVXWnhMdTI2RWNzYkFhNkZ6aG9HdGQwU3ZabnZsd1AybUdUbnIwdVJLcEQ0U1BHek1YSDEyelVCb25qLUVoeWVFQzBVWjlxajZmVGtSQkpNek80aWJXemtSbEMzaTFPOWNKWDR1ay1YSGdNbmtBTkFXaUFUVlVpaUpLa2lRaDN6N2kxcDJZY0x4NU1SU2lfeEE0SkpFTzM4anZGdWVBM3RvU0E?oc=5","date":"2021-12-16","type":"pipeline","source":"businesswire.com","summary":"Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma - businesswire.com","headline":"Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOOVdaR1ZoeEk1RTJzSUhQaXVha2dRTEU5MDN2bS1OcDNVMmZOdjBBdkNiT2x1TDlrbEt1ZDdxbUFZYlVLV1BZYW16U3dJNzN3c2FFbDZwVTBmNURYNkZKVXlXa3o5RVhzNmh2bnJEeDR5OHBhaGU4Tjk1NzQ5Unp6OXhPV0VDWkFhNmduNGMzeHZsNUZZa2dHanZTUHV3QzdyWXJSSVVlTWpqQQ?oc=5","date":"2021-12-14","type":"deal","source":"Fierce Pharma","summary":"CSL to buy Vifor for $11.7B in biopharma's largest M&A deal this year - Fierce Pharma","headline":"CSL to buy Vifor for $11.7B in biopharma's largest M&A deal this year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOMUlkMmNzN012Qlo4S3huWHdTcTFENFdUcWwtRUQyOTY5MnE1S3plNFpRbkM4aWhOR0EyMFp3OUtZNmRMbFNNZ1Z4UTRxS0tkMlVldnlFUXR5VGJrUDhwTlRBVlpXOVJNZGVGSFFxdXN1eGp5SWZwTTRpSEVXd2F5RjBrRTY2czRFalJteXFyRmdOUWFjQ1Z0Uy1FQVUtdEs5Y0pzQUhoZGNZYjhXSktCMnhQczJGNnB4ZGNwNWxPd3hhby0zb0xXWjBnYw?oc=5","date":"2020-03-12","type":"pipeline","source":"businesswire.com","summary":"Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance - businesswire.com","headline":"Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}